Curaleaf Holdings CURLF
OTC CURLF
$9.83 +0.64 (+6.96%)
At close: Aug 19, 2026 · 3:59 PM UTC

Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Other Working Capital Changes of -$7.1 million for Q4 2024, down 705.91% year-over-year from $1.2 million in Q1 2024, and down 166.42% quarter-over-quarter from -$2.7 million in Q3 2024.

Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024) Analysis & Trends

Curaleaf Holdings' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$7.1 million for Q4 2024.

  • In Q4 2024, Other Working Capital Changes fell 705.91% year-over-year to -$7.1 million; the TTM figure through Dec 2024 stood at -$12.1 million (down 6.23% YoY), while the FY2025 annual figure was -$17.9 million, down 9.27% from the prior year.
  • Other Working Capital Changes for Q4 2024 stood at -$7.1 million, down from -$2.7 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $13.8 million in Q4 2023, with the low at -$15.9 million in Q1 2021.
  • The 5-year median for Other Working Capital Changes is $566500.0 (2020), against an average of -$649875.0.
  • The sharpest annual moves came in 2020 and 2021: Other Working Capital Changes sank 1682.44% in 2020, then jumped 1958.42% in 2021.
  • Curaleaf Holdings' Other Working Capital Changes stood at -$23.2 million in 2020, then surged by 109.67% to $2.2 million in 2021, then tumbled by 184.74% to -$1.9 million in 2022, then jumped by 53.78% to -$880000.0 in 2023, then tumbled by 705.91% to -$7.1 million in 2024.
  • Business Quant data shows CURLF's Other Working Capital Changes at -$7.1 million in Q4 2024, -$2.7 million in Q3 2024, and -$880000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Curaleaf Holdings 2.48 Bn 2.38 Bn 169.91 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.09 Mn
Dec 31, 2024 -2.09 Mn
Dec 31, 2024 -2.09 Mn
Sep 30, 2024 1.77 Mn
Sep 30, 2024 1.77 Mn
Sep 30, 2024 1.77 Mn
Dec 31, 2023 13.79 Mn
Dec 31, 2023 13.79 Mn
Dec 31, 2023 13.79 Mn
Sep 30, 2023 549,000.00
Sep 30, 2023 549,000.00
Sep 30, 2023 549,000.00
Dec 31, 2022 838,000.00
Dec 31, 2022 838,000.00
Dec 31, 2022 838,000.00
Sep 30, 2022 293,000.00
Sep 30, 2022 293,000.00
Sep 30, 2022 293,000.00
Jun 30, 2022 3.71 Mn
Jun 30, 2022 3.71 Mn